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Abstract
Since 2007, many cases of fever, thrombocytopenia and leukopenia syndrome (FTLS) have emerged in Henan Province,
China. Patient reports of tick bites suggested that infection could contribute to FTLS. Many tick-transmitted microbial
pathogens were tested for by PCR/RT-PCR and/or indirect immunofluorescence assay (IFA). However, only 8% (24/285) of
samples collected from 2007 to 2010 tested positive for human granulocytic anaplasmosis (HGA), suggesting that other
pathogens could be involved. Here, we used an unbiased metagenomic approach to screen and survey for microbes
possibly associated with FTLS. BLASTx analysis of deduced protein sequences revealed that a novel bunyavirus (36% identity
to Tehran virus, accession: HQ412604) was present only in sera from FTLS patients. A phylogenetic analysis further showed
that, although closely related to Uukuniemi virus of the Phlebovirus genus, this virus was distinct. The candidate virus was
examined for association with FTLS among samples collected from Henan province during 2007–2010. RT-PCR, viral
cultures, and a seroepidemiologic survey were undertaken. RT-PCR results showed that 223 of 285 (78.24%) acute-phase
serum samples contained viral RNA. Of 95 patients for whom paired acute and convalescent sera were available, 73 had
serologic evidence of infection, with 52 seroconversions and 21 exhibiting a 4-fold increase in antibody titer to the virus. The
new virus was isolated from patient acute-phase serum samples and named Henan Fever Virus (HNF virus). Whole-genome
sequencing confirmed that the virus was a novel bunyavirus with genetic similarity to known bunyaviruses, and was most
closely related to the Uukuniemi virus (34%, 24%, and 29% of maximum identity, respectively, for segment L, M, S at
maximum query coverage). After the release of the GenBank sequences of SFTSV, we found that they were nearly identical
(.99% identity). These results show that the novel bunyavirus (HNF virus) is strongly correlated with FTLS.
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Introduction
In May 2007, a county hospital in Xinyang City, Henan
Province treated three patients with fever, abdominal pain,
bloating, nausea, vomiting, gastrointestinal bleeding, and elevated
aminotransferases. The local hospital diagnosed the disease as
acute gastroenteritis. A family member of one patient reported the
disease to the Henan Center for Disease Control and Prevention
(CDC), which sent a team to investigate. The investigation
revealed that the disease had the following characteristics: (1) acute
onset with fever; (2) low white blood cell and platelet counts; (3)
high levels of alanine and aspartate transaminases; (4) positive
urine protein. On the basis of these features, the Henan CDC
excluded the possibility of gastrointestinal disorders. In order to
identify the disease etiology, the Henan CDC team used the above
clinical characteristics as the case definition to search for similar
cases in local hospitals in this and neighboring counties, while
establishing a disease surveillance system that required all medical
institutions to report cases that met the above case definition.
Altogether, 79 cases were found in 2007 in Henan, with 10
fatalities (case fatality rate, 12.7%). All patients were farmers and
resided in mountainous or hilly villages, and many had reported
tick bites 7–9 days before illness, further suggesting an infectious
etiology. In recent years, patients with similar clinical symptoms
were reported with human granulocytic anaplasmosis (HGA;
Anaplasma phagocytophilum) in neighboring Anhui province [1]. In
2005, there was an epidemic of Tsutsugamushi (scrub typhus/
Orientia tsutsugamushi) in this area [2]. Clinical investigations,
epidemiological analyses, and laboratory testing prompted con-
sideration of rickettsial diseases as possible causes, including HGA,
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Tsutsugamushi disease. Specific methods such as polymerase chain
reaction (PCR) and immunofluorescence assays (IFAs) for these
pathogens were then used to determine if these cases were
attributable to HGA or HME [3,4]. However, only 18 of 79
(22.7%) patients were positive for A. phagocytophilum based on
serology and DNA testing. Thus, the disease was initially
considered at least partly caused by A. phagocytophilum, and cases
were provisionally diagnosed as suspected HGA based on clinical
and epidemiological data [1–3,5–7]. In the 3 years since 2007, 206
suspected cases have been discovered in Henan, but there was only
a very low positive rate of A. phagocytophilum confirmation (6 of 206
patients) and no pathogen was isolated. Similar cases were also
reported in the mountainous and hilly areas of nearby Shandong,
Jiangsu, Hubei and Anhui provinces, indicating that the disease
already existed for some time and was widely distributed [7]. We
decided to address the possible causative pathogen underlying this
infection.
On the basis of epidemiological and clinical characteristics, we
considered two types of diseases to be possible: rickettsial and
arthropod-borne viral disease. Because of the low rates of A.
phagocytophilum (rickettsial disease) detection, the research team
intensified its virus search to take into account arthropod-borne
viruses, including Flaviviridae (Dengue viruses [DENV], Japanese
encephalitis virus [JEV]), Togaviridae (Chikungunya virus, Eastern
equine encephalitis virus [EEEV], Western equine encephalitis
virus), and Bunyaviridae (Crimean-Congo hemorrhagic fever virus,
Hantaan virus, and Rift valley fever virus) [8]. Specific PCR assays
for these viruses were used [9–16]. However, none of the patients
from 2007 to 2010 was positive for these viruses, suggesting a new
infectious agent, possibly a virus, remained to be discovered. Thus,
the syndrome was considered an emerging infectious disease and
was named fever, thrombocytopenia and leukopenia syndrome
(FTLS). To identify the etiology, the research team adopted the
following strategy: 1) sequencing of randomly amplified cDNA/
DNA from FTLS patient samples using high-throughput Illumina
sequencing to specifically explore viral communities present in
patients suffering from FTLS, 2) PCR detection of target DNA
directly from clinical specimens, 3) viral culture, 4) immunodetec-
tion methods, and 5) electron microscopic study of the
morphology of the cultured virus.
Culture followed by serological and molecular tests is a standard
approach for identifying an unknown virus. However, culture of
an unknown virus is time-consuming, even taking several years to
confirm a novel infection like HIV [17]. Otherwise, virus culture
often fails because of the lack of cell lines capable of supporting
propagation of viruses (e.g., hepatitis B and C virus). Methods for
cloning nucleic acids of microbial pathogens directly from clinical
samples offer opportunities for pathogen discovery, thereby laying
the foundation for future studies aimed at assessing whether novel
or unexpected viruses play a role in disease etiology. Random
PCR and subtractive cloning sequencing have identified previ-
ously unknown pathogens as etiological agents of several acute and
chronic infectious diseases [18,19]. Recently, high-throughput
sequencing approaches have been used for pathogen detection and
discovery in clinical samples [20–22]. We also developed a method
for exploring viruses, both known and novel, using high-
throughput Illumina sequencing. In this study, high-throughput
Illumina sequencing was applied to specifically explore the viral
communities in patients with FTLS, using healthy subjects as
controls. Here, we provide evidence for the discovery of a novel
bunyavirus associated with FTLS through high-throughput
sequencing. Subsequent culture of the virus and PCR detection
of the specific virus in patient specimens confirmed these findings.
Materials and Methods
Ethics statement
This research was approved by the Review Board of the Center
for Disease Control and Prevention of Henan Province, the
Review Board of the Center for Disease Control and Prevention of
Xinyang city, the Review Board of Beijing Institute of Genomics,
the Review Board of Beijing Genomics Institute in Shenzhen,
and the Review Board of the Institute of Microbiology and
Epidemiology. All participants gave written informed consent for
use of their samples in research.
Biosafety
Given the serious nature of FTLS, it was decided to handle all
clinical specimens and perform all experiments involving live virus
in a biosafety level-3 (BSL-3) facility.
Clinical samples
We studied 285 Henan province patients with FTLS whose
samples were submitted to the Henan Province CDC between
May 2007 and July 2010. Acute-phase serum samples from all
patients were collected. Paired convalescent sera were available
from 95 patients.
Diagnostic testing of sera for microbial agents possibly
related to FTLS
Sera were tested by reverse transcription (RT)-PCR, PCR, and/
or indirect IFA serological assays for a number of microbial agents,
including A. phagocytophilum, Ehrlichia chaffeensis, Dengue fever virus,
Japanese encephalitis virus, Chikungunya virus, Eastern equine
encephalitis virus, Western equine encephalitis virus, Crimean-
Congo hemorrhagic fever virus, Rift Valley fever virus, Sandfly
fever Naples Sabin virus, and Hantavirus [3–6,9–16,23]. Antigen
slides for diagnosis of HGA (A. phagocytophilum) were purchased
from Focus Diagnostics (IF1450G, CA, USA). Antigen slides for
diagnosis of other pathogens were prepared by our laboratories.
Fluorescein isothiocyanate (FITC)-conjugated goat anti-human
Author Summary
Initially in 2007, and again between 2008 and 2010, cases of
a life-threatening disease with sudden fever, thrombocyto-
penia, and leukopenia were reported in Henan Province,
China. Patient reports of tick bites suggested that this
disease could be infectious or tick-transmitted. Many
patients were provisionally diagnosed with human granu-
locytic anaplasmosis (HGA). However, only 24 of 285 (8%)
had objective evidence of HGA, suggesting that other
pathogens likely contributed to fever, thrombocytopenia
and leukopenia syndrome (FTLS). Illumina sequencing was
used for direct detection in clinical samples of pathogens
possibly associated with FTLS. A novel bunyavirus was
found only in samples from FTLS patients. Further
epidemiologic and laboratory investigation confirmed that
the novel bunyavirus was associated with FTLS. The results
illustrate that metagenomic analysis is a powerful method
for the discovery of novel pathogenic agents. Combined
with epidemiologic investigation, it could assist in rapid
diagnosis of unknown diseases and distinguish them from
other diseases with similar symptoms caused by known
pathogens.
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(Beijing, China).
Sample processing for Illumina sequencing
Equal quantities (100 mL) of acute-phase sera from 10 FTLS
patients who had a history of tick bite were pooled and centrifuged
at 1000 x g for 10 minutes. The supernatant was collected for
DNA and RNA extraction. The same was done for 10 sera from
healthy subjects (control).
DNA and RNA extraction
DNA was extracted from 140 mL of each sample using the
QIAamp DNA mini Kit (Qiagen, 51304) according to the
manufacturer’s instructions. DNA was eluted from the columns
with 50 mL water containing 20 mg/mL RNaseA. After incubation
at 37uC for 15 minutes to eliminate RNA, DNA was used
immediately or stored at 280uC.
Total RNA was extracted from 140 mL of each sample using the
QIAamp viral RNA mini Kit (Qiagen, 52904) according to the
manufacturer’s instructions. RNA was eluted from the columns
with 50 mL of diethyl pyrocarbonate (DEPC)-treated water
containing 1 U DNaseI. Samples were incubated at 37uC for 15
minutes to eliminate human DNA, followed by DNase inactivation
at 95uC for 10 minutes. RNA was used immediately or stored at
280uC.
Reverse transcription
cDNA was synthesized from 6 mL of RNA by reverse
transcription at 45uC for 50 minutes in a 20-mL solution
containing 50 mM Tris–HCl (pH 8.3), 75 mM KCl, 3 mM
MgCl2, 10 mM DTT, 100 ng of random hexamer primers,
200 U of Superscript II (Invitrogen, 18064–014), 25 U of RNasin
(Promega, N2511), and 0.5 mM dNTPs.
Random hexamer PCR
Random hexamer PCR was carried out in a 25-mL mixture
containing 4 mL of cDNA or DNA, 10 mM Tris-HCl (pH 8.4),
50 mM KCl, 2.5 mM MgCl2, 100 mM dNTPs, 1 U Taq DNA
Polymerase (Promega, M1661) and 100 ng of random hexamer
primers containing a linker (5’-GCCGGAGCTCTGCAGAA-
TTCNNNNNN-3’). After denaturing at 95uC for 5 minutes,
targets were amplified by 45 cycles of 95uC for 30 seconds, 40uC
for 30 seconds, 50uC for 30 seconds, and 72uC for 90 seconds. The
amplified products were detected by agarose gel electrophoresis.
Pure water was used as a negative control.
High-throughput sequencing by the Illumina method
FTLS patient and control genomic DNA/cDNA libraries were
constructed according to the manufacturer’s instructions (Illu-
mina). In brief, RT-PCR and PCR products were roughly
quantified by UV absorption and equal amounts of each sample
were mixed. Nucleic acids within the mixtures were sheared by
sonication, and fragments in the 150–180-bp range were collected
by cutting bands from an agarose gel after electrophoresis. The
sheared DNA and cDNA ends were repaired using Klenow DNA
polymerase, after which 5’ termini were phosphorylated and 3’
termini were polyadenylated. The adaptors were added, PCR
enrichment was performed, and 150–180-bp fragments were
collected for sequencing by the Illumina method.
The sequencing procedure was performed according to the
manufacturer’s instructions (Illumina). In this process, template
library DNA was hybridized to the surface of the flow cells and
multiple copies of DNA were made to form clusters using the
Illumina cluster station. Workflow steps included template
hybridization, isothermal amplification, linearization, and final
denaturation and hybridization of sequencing primers. Paired-end
sequencing (100 cycles) was performed using a four-color DNA
Sequencing-By-Synthesis (SBS) technology following the manu-
facturer’s instructions.
Short Oligonucleotide Analysis Package (SOAP) was used to
handle the large amounts of short reads generated by parallel
sequencing [24]. Briefly, after filtering out highly repetitive
sequences and adaptor sequences, the overlapping datasets
between FTLS and healthy subjects were analyzed by subtracting
fragments that mapped to both host genomic-plus-transcript and
bacteria databases. The non-redundant reads were mapped onto a
virus database downloaded from NCBI (ftp://ftp.ncbi.nih.gov/
genbank/). The resulting alignments were filtered to identify
unique sequences by examining alignment (identity $80%) and E-
value scores (e#10
22). Filtered unique alignments were examined
in the taxonomy database (NCBI) using a custom software
application written in Perl (BioPerl version 5.8.5). Unmapped
reads were examined in GenBank nucleic acid and protein
databases using BLASTn and BLASTx, respectively [25–27].
Unique alignments were examined in the taxonomy database
(NCBI). Sequences without hits were placed in the ‘‘unassigned’’
category. Sequences were phylotyped as human, bacterial, phage,
viral, or other based on the identity of the best BLAST hit.
Considering misannotation and low-complexity for Illumina short
reads, sequences assigned to the same virus family were further
assembled into contigs with Velvet 1.1.04 (K-mer length =21;
coverage cutoff: default 0; Insert length: PE only; minor contig
length: 42) for direct comparison with GenBank nucleic acid
databases using BLASTn [28]. Contigs were also blasted with
GenBank protein databases using BLASTx [28]. An E-value cutoff
of 1610
25 was applied to both BLASTn and BLASTx analyses.
Sequences phylotyped as viral were placed in the ‘‘viral’’ category.
RT-PCR detection of the bocavirus
Our mass sequencing data revealed that some sequences
showed possible infection with human bocavirus, which belongs
to the Parvoviridae family. PCR performed to detect human
bocavirus tentatively identified in sera from FTLS patient samples
amplified a 291-bp fragment of the NS1 gene, as described
previously [29]. Amplified products were detected by agarose gel
electrophoresis and sequenced using an ABI 3730 DNA
Sequencer.
RT-PCR detection of the novel bunyavirus
Our mass sequencing data revealed a 168-bp sequence (C361,
Accession: HQ412604) indicating the possible presence of a novel
virus with closest identity (i.e., lowest E-value) to Tehran virus which
belongs to the Phlebovirus genus of the Bunyaviridae family. We
developed a PCR strategy based on the 168-bp sequence identified
in sera from FTLS patient samples to detect the novel bunyavirus
using forward (PF: 5’-GAC ACG CTC CTC AAG GCT CT-3’)
and reverse (PR: 5’-GCC CAG TAG CCC TGA GTT TC-3’)
primers designed with Primer3 (Supplementary Figure S1). PCR
was carried out in a 25-mL mixture containing 4 mL of cDNA,
10 mM Tris–HCl (pH 8.4), 50 mM KCl, 2.5 mM MgCl2,
100 mM dNTPs, 1 U Taq Pol (Promega, M1661), 0.25 mM
forward primer, and 0.25 mM reverse primer. Thermocycling
conditions were as follows: 95uC for 4 minutes (denaturation),
followed by 35 cycles of 94uC for 30 seconds, 54uC for 30 seconds,
and 72uC for 30 seconds. Amplified products were detected by
agarose gel electrophoresis and sequenced using an ABI 3730
DNA Sequencer.
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The Vero E6 cell line (African green monkey kidney cell) was
selected for isolation of the novel bunyavirus associated with FTLS
because it supports the growth of many bunyaviruses [30,31].
Vero E6 cell lines were inoculated with six serum samples that
contained novel bunyavirus RNA. Each sample underwent at least
three cell culture passages in Vero E6 cell line before being
considered negative. Medium was replenished on day 7, and
cultures were terminated 14 days after inoculation. All cultures
were observed daily for cytopathic effect (CPE). Virus-infected
cells and uninfected cells were also examined for the novel
bunyavirus by RT-PCR at each passage. Vero cell cultures with
obvious CPE and containing novel bunyavirus RNA were further
analyzed by morphology, genome sequencing, and serology.
Transmission electron microscopy
Cells showing CPE and containing novel bunyavirus RNA were
collected for thin-section electron microscopy. After discarding the
culture supernatant, virus-infected cells (50 mL) were mixed 1:1
with 4% glutaraldehyde (paraformaldehyde), placed onto For-
mvar-carbon-coated grids, and stained with 1% methylamine
tungstate. Specimens for thin-section electron microscopy were
prepared by dehydrating washed cell pellets with serial dilutions of
acetone and embedding in epoxy resin. Ultrathin sections were cut
on an Ultracut LKBV ultramicrotome, stained with uranyl acetate
and lead citrate, and examined under a transmission electron
microscope (JEM-1400).
Genome sequencing
The medium from 20 mL of novel bunyavirus-infected Vero E6
cells was centrifuged at 1,000 x g for 10 minutes and then at 4,000 x
g for 10 minutes, after which the supernatant was collected.
PEG8000 was added to the supernatant at a final concentration of
10%(w/v) followed by centrifugation at 20,000 x g for 2 hours. The
pellet was resuspended in 2 mL 16phosphate-buffered saline (PBS)
for RNA extraction. Random RT-PCR was performed, and the
products(500–1500 bps) werecollected and ligated into thepGEM-
T vector (Promega, A3600) by incubating overnight at 16uC.
Escherichia coli JM109 were transformed with the ligation mixture
and cultured on LB agar containing X-gal. White clones were
sequenced using an ABI 3730 DNA Sequencer. Contaminating
human and extraneous sequences were eliminated using Cross-
Match, and the complete sequence was assembled using Phred-
Phrap-Consed[32].BridgeRT-PCRwasemployedforgap-closure.
Phylogenetic analysis
Phylogenetic analyses were performed using the neighbor-joining
method in the MEGA software package, version 4.0.2 [33]. Available
nucleotide or protein sequences from known viruses were obtained
from GenBank for inclusion in the phylogenetic trees. Selected
sequences from GenBank included those with the greatest similarity
to the sequence read in question based on BLAST alignments as well
as representative sequences from all major taxa within the relevant
Bunyaviridae family. To further establish the relationships between the
new virus and the members of the Phleboviruses genus, we included all
sequences for phleboviruses available in GenBank. Branching orders
of the phylograms were verified statistically by resampling the data
1,000 times in a bootstrap analysis with the branch-and-bound
algorithm, as applied in MEGA.
Serologic detection by indirect IFA
After successful isolation of the novel bunyavirus, we developed
an indirect IFA to detect specific antibodies in patient serum
specimens, as previously described [4]. In brief, monolayers of
virus-infected Vero E6 cells showing CPE and containing novel
bunyavirus RNA were harvested, and one volume of infected cells
was mixed with 0.5 volumes of non-infected cells. The mixture was
centrifuged at 1,000 x g for 10 minutes, after which cells were
resuspended in 16PBS, spotted onto 12-well glass slides, and fixed
with acetone for 10 minutes. Sera from patients with FTLS
(including 285 acute-phase samples and 95 paired sera), patients
with respiratory diseases (80 serum samples), and healthy subjects
(50 serum samples) were applied to the cells. Samples (diluted 1:20
in PBS) were screened by first spotting 50 mL of each serum
sample per well and incubating for 30 minutes at 37uC. After
washing for 10 minutes in PBS, 20 mL of FITC-conjugated goat
anti-human IgG (Sihuan Sci-Technics Company, Beijing, China)
diluted 1:40 in buffer containing Evans blue was added to each
well and incubated for 30 minutes. After washing, slides were
mounted in glycerin and examined by immunofluorescence
microscopy. A titer of 1:20 was considered positive.
Results
Epidemiology and clinical features of the disease
All 285 patients with FTLS were from the Henan Province of
China and were provisionally diagnosed as suspected HGA on the
basis of similar clinical manifestations [5,7]. They represented four
different epidemiologically linked sporadic cases and a few clusters
of cases including 79 patients in 2007, seven patients in 2008, 47
patients in 2009, and 152 patients in 2010. The patients presented
mainly between April and October, peaking in April-May during
the tea-picking season in Henan. All patients resided in mountain-
ous and hilly rural areas. In our study, 238 of 285 patients tested
positive for novel bunyavirus infection by RT-PCR and/or IFA.
Epidemiology and clinical features of the disease in
laboratory-confirmed patients
The median age of patients was 57.2 years (range, 23–88) and
the male-to-female ratio was 1 to 2.27; 219 patients (92.02%) were
farmers and 19 (7.98%) were workers or students. Among patients,
52 (21.85%) reported a tick bite within 2 weeks (5–14 days) before
the onset of clinical manifestations; the remaining patients did not
recall receiving a tick bite.
The main clinical features in confirmed patients included
sudden onset of fever (.37.5uC 240uC) lasting up to 10 days,
fatigue, anorexia, headache, myalgia, arthralgia, dizziness, en-
larged lymph nodes, muscle aches, vomiting and diarrhea, upper
abdominal pain, and relative bradycardia (Table 1). A small
number of cases suffered more severe complications, including
hypotension, mental status alterations, ecchymosis, gastrointestinal
hemorrhage, pulmonary hemorrhage, respiratory failure, dissem-
inated intravascular coagulation, multiple organ failure, and/or
death. Most patients had a good outcome, but elderly patients and
those with underlying diseases, neurological manifestations,
coagulopathy, or hyponatremia tended to have a poorer outcome.
Laboratory tests showed that confirmed patients characteristi-
cally developed thrombocytopenia, leukopenia, proteinuria, and
elevated serum aspartate aminotransferase (AST) and alanine
aminotransferase (ALT) levels (Table 2). Biochemical tests
revealed generally higher levels of lactate dehydrogenase, creatine
kinase, AST and ALT enzymes, especially AST.
Metagenomic analysis and identification of unknown
pathogen
One lane for each of the two sample pools (FTLS and healthy
controls), each consisting of 10 samples, was sequenced. The
Metagenomic Analysis: Discovery of a New Bunyavirus
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were 98.08% (10,198,407/10,397,161) and 97.88% (10,250,809/
10,472,315), respectively. Unique, high-quality sequence reads
were then classified into broad taxonomic groups based on the
taxonomy of the most frequent top-scoring BLAST matches for
each sequence. Virus sequences constituted 0.0065% (67,969) and
0.0048% (50,677) of the reads in FTLS and control libraries,
respectively (Table 3). After contig assembly, the number of
sequences phylotyped as ‘‘viral’’ decreased to 3,163 and 2,412,
respectively, in the two pools (Table 4). To screen for possible
viruses, we focused exclusively on viruses that were present in
patient sera.
For detection of known viruses, non-redundant reads were
directly aligned with the GenBank database of nucleic acids using
BLASTn software. Some sequences from Adenoviridae (human
adenovirus), Herpesviridae (herpesvirus), Papillomaviridae (papilloma-
virus) and Retroviridae (human endogenous retrovirus) were
detected in both FTLS patients and healthy subject samples.
Some hepatitis B virus (HBV) and human bocavirus sequences
were detected only in patient sera, indicating the presence of HBV
and human bocavirus infections among these patients. To detect
novel viruses, we examined sequence data against the GenBank
protein database using BLASTx. An analysis of the deduced
protein sequences revealed four different virus families in sera
from FTLS patients (Table 4). Among these were viruses from
Hepadnaviridae, which are not known to cause FTLS; Torque teno
virus (TTV) from Anelloviridae, which has been reported to be
associated with certain inflammatory states [34], but is not known
to be transmitted by arthropods; and viruses from the Parvoviridae
family, including human bocavirus, which could cause febrile
illness and signs of FTLS. Although human bocaviruses are not
known to be transmitted by arthropods, feline panleukopenia
virus, a parvovirus, is strongly suspected to be transmitted by
arthropods [35]. All family Parvoviridae sequences detected in FTLS
samples were also assembled and their protein sequences deduced.
Included among these samples were four fragments, all of which
were found to be highly homologous to human bocavirus; one
fragment showed the greatest similarity to human bocavirus 2
isolate 53044 (identity =86%) with the lowest E-value (8610
217).
Table 1. Symptoms of 238 patients with FTLS at
presentation.
Clinical symptoms Number (%)
Fever 232 (97.48)
Fatigue 223 (93.70)
Anorexia 219 (92.02)
Body sores 193 (81.09)
Nausea 181 (76.05)
Myalgia 165 (69.33)
Coarse breathing sounds 170 (71.43)
Chill 171 (71.85)
Diarrhea 156 (65.55)
Dizziness 164 (68.91)
Vomiting 153 (64.29)
Headache 146 (61.34)
Abdominal pain 134 (56.30)
Enlargement of lymph nodes 128(53.78)
Cough 119 (50.00)
Sputum production 89 (37.39)
Arthralgia 80 (33.61)
Skin rash 19 (7.98)
doi:10.1371/journal.ppat.1002369.t001
Table 2. Initial laboratory findings of 238 patients with FTLS.
Laboratory variables Mean (range) Normal range Number of abnormal (%)
White-cell count 2.31(2.19–2.42) 4–11610
9/L
Leukopenia 234 (98.32)
Platelet count 58.89(55.26–62.51) 100–300610
9/L
Thrombocytopenia 232 (97.48)
Alanine aminotransferase (ALT) 307.50(256.42–358.58) 0–40 U/L
Elevated alanine aminotransferase 234 (98.32)
Aspartate aminotransferase (AST) 349.14(294.20–404.08) 0–40 U/L
Elevated aspartate aminotransferase 234 (98.32)
Lactate dehydrogenase(LDH) 532.95(482.72–583.17) 135–225 U/L
Elevated lactate dehydrogenase 221 (92.86)
Positive urine protein 205 (86.13)
Calcium 1.94(1.89–1.99) 2.3–2.7 mmol/L
Low calcium 206 (86.55)
Creatine kinase (CK) 53.24(45.82–60.67) 0–25 U/L
Elevated creatine kinase 166 (69.75)
Creatine phosphokinase (CPK) 481.66(387.68–575.65) 24–195 U/L
Elevated creatine phosphokinase 149 (62.61)
Sodium 133.71(132.29–135.13) 135–145 mol/L
Low sodium 113 (47.48)
doi:10.1371/journal.ppat.1002369.t002
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sample raw reads data valid reads data Reads removed host viruses reads data
Patients’ Sera 10397161 10198407 3709639 67969
Sera control 10472315 10250809 3449274 50677
Criteria for SOAP including ID$80%, E-value#1e-2 and Match query$0.7.
doi:10.1371/journal.ppat.1002369.t003
Table 4. sequence reads with limited BLASTx identity to known viruses.
Virus family* Genus/Species Name (Top Hit) Sera from patients Sera from healthy people
Read Counts Read Counts
Anelloviridae Alphatorquevirus 185
Gammatorquevirus 11
Iotatorquevirus 16
Thetatorquevirus 2
Bunyaviridae Hantaan virus 11
Nairovirus 160
Orthobunyavirus 43
Phlebovirus 121
Tospovirus 5
Hepadnaviridae Hepatitis B virus 230
Parvoviridae Human bocavirus 12
Aleutian mink disease virus 2
Astroviridae Human astrovirus 22
Adenoviridae Atadenovirus 18
Aviadenovirus 24 13
Ichtadenovirus 11
Mastadenovirus 142 529
Siadenovirus 7 85
Alloherpesviridae Cyprinid herpesvirus 1 85 100
Arenaviridae Lymphocytic choriomeningitis virus 47 22
Herpesviridae Cytomegalovirus 18
Lymphocryptovirus 31
Iltovirus 49
Macavirus 16
Muromegalovirus 28 3
Percavirus 35 21
Rhadinovirus 81
Simplexvirus 93 141
Varicellovirus 273 211
Papillomaviridae Human papillomavirus 10 24 137
Paramyxoviridae Human metapneumovirus 14 4
Human respiratory syncytial virus 2 83
Retroviridae Alpharetrovirus 651 273
Betaretrovirus 337
Deltaretrovirus 289 87
Gammaretrovirus 166 568
Epsilonretrovirus 37
*Bold indicates virus families only found in FTLS patient sera. An E-value cutoff of 1e-5 for BLASTx was applied.
doi:10.1371/journal.ppat.1002369.t004
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PLoS Pathogens | www.plospathogens.org 7 November 2011 | Volume 7 | Issue 11 | e1002369Human bocavirus was further detected by PCR in the pool of 10
serum samples, but only one individual sample within the pool
tested positive for bocavirus. The final virus family detected in sera
from FTLS patients was the Bunyaviridae family, which contains
viruses known to cause FTLS after tick bites [8,30]. All family
Bunyaviridae sequences detected in FTLS samples, including 11
fragments (1 S-segment, 2 M-segments, and 8 L-segment frag-
ments), were assembled and their protein sequences were deduced.
Among these 11 novel virus fragments was a 168-bp fragment
(C361, Accession: HQ412604) of the polymerase gene that showed
the greatest similarity to Tehran virus (identity =36%) with the
lowest E-value (3610
27). This suggested the presence of a novel
virus or a known virus whose genome had not yet been sequenced.
To more accurately assess the genetic relationships to known
viruses, we constructed a phylogenetic tree using a neighbor-joining
method [33]. The result showed that the potentially novel virus
clustered with Toscana virus, Uukuniemi virus, and Rift Valley fever
virus of the Phlebovirus genus (Figure 1A). The pools of 10 serum
samples from patients and 10 serum samples from healthy subjects
were also screened by PCR for the presence of the novel bunyavirus.
All 10 samples from patients tested positive for the novel bunyavirus;
however, all 10 samples from healthy subjects tested negative. Thus,
we further focused on the virus from the family Bunyaviridae.
Confirmation of the presence of the novel virus in
patients’ sera
Using specifically designed RT-PCR primers, we detected viral
RNA in 223 of the 285 acute serum samples tested (Table 5). The
specificity of the RT-PCR was confirmed by sequencing selected
PCR products. None of the 80 sera from patients with respiratory
diseases or the 50 sera from healthy subjects was positive using the
novel virus-specific RT-PCR.
Isolation of the novel virus
Six acute serum samples that tested positive for the novel
bunyavirusbyspecific RT-PCRwereinoculatedonto Vero E6cells,
and four virusstrains were isolated.The initialCPE analysis showed
rounded refractile cells 2–4 days after inoculation. CPE did not
progress in the initial cultures, but appeared slightly at 24 hours in
subsequent passages (Figure 2A). RT-PCR revealed the presence of
RNA for the novel bunyavirus in all four virus strains, and all
isolates reacted with the serum of a convalescent patient in IFA
(Figure 2C). In addition, electron microscopy showed the presence
of virus particles approximately 80–90 nm in diameter—a size
compatible with a bunyavirus (Figure 3). Virus particles were
presumably localized to the Golgi apparatus (Figure 3).
Confirmation of the isolated virus by direct sequencing
Genome sequencing of one isolate (HN01) revealed three
segments of negative polarity, single-stranded RNA, including a
large segment (L; GenBank HQ642766), a medium-sized segment
(M; GenBank HQ642767), and a small segment (S; GenBank
HQ642768). The deduced amino acid sequence of the L segment
had the highest homology (34%, E value =3610
2163) to RNA
polymerase of the Uukuniemi virus of the Phlebovirus genus,
whereas the M segment had the highest homology (26%, E value
=8 610
255) to glycoprotein genes of the Punta Toro virus in the
Phlebovirus genus. Of the two proteins encoded by the ambisense S
segment, one had the highest homology to nucleocapsid protein
(39%, E value =3610
240) of the Rift Valley Fever virus, and the
other had the highest homology to nonstructural protein genes
(24%, E value =0.049) of the Punique Virus, both of which
belong to the Phlebovirus genus. Collectively, these findings confirm
that this virus belongs to the Phlebovirus genus of Bunyaviridae.
During the revision of this manuscript, some new sequences of
SFTSV (severe fever with thrombocytopenia syndrome) were
released. A comparison of these new SFTSV sequences with the
sequence of this novel virus showed that they were highly
homologous (.99% identity). Using sequences of Phlebovirus
available in GenBank, a phylogenetic analysis showed that,
although most closely related to the Uukuniemi virus of the
Phlebovirus genus (34%, 24%, and 29% of maximum identity,
respectively, for segment L, M, S at maximum query coverage),
Table 5. Detection of novel FTLS bunyavirus-specific IgG
antibody and viral RNA by IFA and RT-PCR.
Course of Disease
a Number of Samples Number of Positive
IgG (%) RNA (%)
1–3 87 4 (4.59) 72 (82.75)
4–6 134 27 (20.14) 117 (87.31)
7–14 64 49 (76.56) 34 (53.12)
Total 285 80 (28.07) 223 (78.24)
a: Days were counted based on the onset of symptoms.
doi:10.1371/journal.ppat.1002369.t005
Figure 1. Phylogenetic analysis of novel bunyavirus proteins. Phylogenetic trees were generated by comparing the translated amino acid
sequences of individual sequence reads to the corresponding sequences from known bunyaviruses using a neighbor-joining method. The horizontal-
line distance represents the number of sites at which the two compared sequences are different. Bootstrap values deduced from 1000 replicates. A:
C361 fragment (Accession number HQ412604). B: FTLS bunyavirus (Henan isolate), Segment L (Accession number HQ642766). C: FTLS bunyavirus
(Henan isolate), Segment M (Accession number HQ642767). D: FTLS bunyavirus (Henan isolate), Segment S (Np) (Accession number HQ642768). E:
FTLS bunyavirus (Henan isolate), Segment S (Ns) (Accession number HQ642768).
doi:10.1371/journal.ppat.1002369.g001
Figure 2. Vero E6 cells inoculated with acute serum specimens
from patients with FTLS. The typical early CPE seen with novel
bunyavirus isolates from patients with FTLS is shown in part A (640).
Mock-inoculated Vero cells are shown in part B (640). Infected Vero
cells reacted with the serum of a convalescent FTLS patient in an
indirect IFA in part C (6400).
doi:10.1371/journal.ppat.1002369.g002
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SFTSV sequences, were highly divergent (Figure 1B–1E).
Antibody response to the bunyavirus
IgG antibodies to the novel bunyavirus were detected in 80 of
285 acute-phase serum samples from patients with FTLS (Table 5).
Of 95 patients from whom paired acute- and convalescent-phase
sera were available, 52 had seroconversions and 21 had greater
than 4-fold increases in antibody titer to the virus. Six had less
than a 4-fold increase in antibody titer to the virus, but all paired
sera tested positive. Sixteen patients tested negative to the virus,
suggesting that some non-FTLS patients with similar symptoms
were included in this study, a situation that is not surprising given
that FTLS is a newly emerging disease. The acute-phase sera of
four patients from whom the virus was isolated tested negative for
IgG antibody to the virus. All convalescent sera obtained 2 months
later from the same four patients contained IgG antibody to the
virus. None of the 130 sera from patients with respiratory diseases
or healthy subjects had detectable antibody.
Discussion
Since 2007, there has been an increase in reported cases of
FTLS in Xinyang City, Henan Province. These patients were
tentatively diagnosed as having A. phagocytophilum infection.
However, only a few (8.4%, 24/285) such patients had evidence
for A. phagocytophilum infection, and none of the 285 patients tested
positive for the many other pathogens capable of causing similar
clinical and laboratory manifestations that were also investigated.
These findings suggested novel infectious agents, including viruses.
Traditionally, virus culture is very important for identifying an
unknown viral infection. Before performing the Illumina sequenc-
ing strategy, we attempted viral and rickettsial culture with DH82
and BHK cell lines, but the lack of an obvious CPE led us to
initially abandon this approach. Here, mass sequence data
obtained by Illumina sequencing revealed four virus families that
appeared only in FTLS patient sera. Among these four virus
families, viruses from the Parvoviridae and Bunyaviridae families
reportedly can cause signs of FTLS and be transmitted by
arthropods. However, only one sample from a pool of ten samples
tested positive for bocavirus by PCR, suggesting that bocavirus
from the Parvoviridae is not likely involved in FTLS. For viruses in
the Bunyaviridae family, the incidence of infection is closely linked to
vector activity. For example, tick-borne viruses are more common
in the late spring and late summer when tick activity peaks.
Human infections with certain Bunyaviridae, such as Crimean-
Congo hemorrhagic fever virus, are associated with high levels of
morbidity and mortality [30]. Considering the tick-bite history of
many FTLS patients, we focused on Bunyaviridae family viruses.
The entire Bunyaviridae family contains more than 300 members
arranged in four genera of arthropod-borne viruses (Orthobunya-
virus, Nairovirus, Phlebovirus and Tospovirus) and one genus (Hantavirus)
of rodent-borne viruses [30,36]. The Phlebovirus genus currently
comprises 68 antigenically distinct serotypes, only a few of which
have been studied. The 68 known serotypes are divided into two
groups: the Phlebotomus fever group (the sandfly group,
transmitted by Phlebotominae sandflies) comprises 55 members,
and the Uukuniemi group (transmitted by ticks) comprises the
remaining 13 members. Of these 68 serotypes, eight are linked to
disease in humans, including the Alenquer, Candiru, Chagres,
Naples, Punta Toro, Rift Valley fever, Sicilian, and Toscana
viruses [30]. Phleboviruses have tripartite genomes consisting of a
large (L), medium (M), and small (S) RNA segment.
In screening for unknown viruses, species hits alone likely carry
little weight. Thus, we used all sequences in the family Bunyaviridae
for our analysis. A 168-bp fragment of the polymerase gene with
the lowest E-value and high sequence identity was used as the
sequence of the unknown virus. This virus sequence was detected
in all 10 pooled samples, indicating that the virus is involved in
FTLS. After detecting a possible novel bunyavirus through high-
throughput Illumina sequencing, we inoculated Vero cell lines,
which are known to be sensitive to phleboviruses, with sera from
six positive patients and were subsequently able to detect the virus
by RT-PCR [30,31]. Although the CPE was modest, RT-PCR
confirmed the infection. Genome sequencing was performed and a
phylogenetic analysis of the genome sequence showed that this
virus clustered into the Phlebovirus branch, but was divergent from
other known phleboviruses. These results confirm the novelty of
this virus within the Phlebovirus genus of the family Bunyaviridae [36].
Furthermore, virus size and propagation in cells were similar to
that of the bunyaviruses.
PCR and serological tests were performed to further test the
causal link between the new virus and FTLS. Although we have
not completely fulfilled Koch’s postulates, evidence implicating
this new bunyavirus in the outbreak of the disease among patients
with FTLS is compelling.
In view of the fact that the disease is caused by a novel
bunyavirus, and taking into account that the disease was first
discovered in Henan (HN), we propose the name "Henan Fever"
for the FTLS disease cause by the novel virus (proposed name
‘‘Henan Fever Virus’’ [HNF virus]). Since the submission of this
manuscript, a bunyavirus was identified as the cause of FTLS in
Chinese patients from other regions of China, and the authors
have named this virus ‘‘SFTSV’’ to indicate that it is the cause of
severe fever with thrombocytopenia syndrome [37]. After release
of the GenBank sequences referred to in the Yu paper, we
compared the sequences of SFTSV with those of FTLSV and
found that they were nearly identical (.99% identity). As we first
identified the syndrome in 2007 and described the presence of the
virus in patients between 2007 and 2010, we suggest that the name
‘‘HNF virus’’ should take precedence. The most distinctive feature
of the current work includes the use of an unbiased metagenomic
approach for viral pathogen discovery that facilitated the rapid
creation and implementation of standard culture, serological, and
molecular diagnostic approaches. However, there are other
Figure 3. Thin-section electron microscopy of novel FTLS-
associated bunyavirus Grown in Vero E6 Cells.
doi:10.1371/journal.ppat.1002369.g003
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by Yu et al; notably, we observed slight, but distinctive, CPE in
Vero cells. The reason for the failure to observe CPE in Vero cells
infected with the ‘‘SFTSV’’ bunyavirus [37], whose genome is
nearly identical to that of bunyavirus isolated from our FTLS
patients, is unclear. Perhaps this reflects the fact that the ensuing
CPE is not dramatic. Alternately, this could indicate the existence
of distinct viral strains that vary in pathogenicity, virulence, and
possibly even disease manifestations. This is an area of active study
in our laboratories.
The discovery of this new virus will assist in the rapid diagnosis
of this disease and help to distinguish it from other diseases caused
by pathogens such as A. phagocytophilum, E. chaffeensis, Crimean-
Congo hemorrhagic fever virus, Hantavirus, dengue virus,
Japanese encephalitis virus, and Chikungunya virus. Furthermore,
the availability of the new virus will facilitate the future
development of new therapeutic interventions, such as vaccines
and drugs.
Supporting Information
Figure S1 Sensitivity and dynamic range of real-time PCR in
the detection of bunyavirus RNA. To evaluate sensitivity of our
RT-PCR, a real-time PCR was performed. Serial dilutions of in
vitrobtranscribed bunyavirus RNA sequences were tested. A wide
linear range (from 5 copies to 5610
7 copies of control RNA per
reaction) was detected in this assay.
(TIF)
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